Medical devices, healthcare technology and the business of care
510(k) clearance · K254051

Extroducer Infusion Catheter System

SmartWise Sweden AB · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONK254051

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 11, 2026 for the Extroducer Infusion Catheter System, submitted by SmartWise Sweden AB of Tullinge, Sweden, under 510(k) number K254051. The application was received December 17, 2025 and reviewed under regulation 870.1210 in the Cardiovascular specialty and panel, with classification product code KRA and device classification name Catheter, Continuous Flush. SESE denotes 510(k) clearance, not premarket approval.

The FDA letter excerpt states the system is intended for infusion of diagnostic or therapeutic solutions into the extravascular area, but the excerpt is truncated and the full indication is not available here. The record lists a Traditional summary, no third-party review, no combination product status and no authorized predetermined change control plan. The reviewed summary document and any performance data are not included in the public information, so the basis for the equivalence determination remains unknown.

No component-level change, predicate device or clinical evidence is described in the available text; readers should consult the full K254051 decision documents before drawing clinical or regulatory conclusions.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 11, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254051
Regulatory pathway
510(k) premarket notification
Product code
KRA
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Continuous Flush.

Product code
KRA
FDA device class
2

FDA decision timeline

  1. K254051 received

    Application receipt date recorded by FDA.

  2. K254051 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code KRA

Product / regulatory recordCompanyPathwayDecision dateSource
Terumo Clinical Supply Co., Ltd.510(k) clearanceNov 5, 2026FDA
Trisalus Life Sciences510(k) clearanceSep 21, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

SmartWise Sweden AB

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Tullinge

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records